Dec 07 2025
Disc Medicine, Inc. (IRON) Discusses ASH Conference Data Updates and Portfolio Progress Including Anemia and Iron Restriction Programs Transcript
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Jayud Global Logistics Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - JYD
This Artificial Intelligence (AI) Infrastructure Stock Could Be the Nvidia of 2026
AVTR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Avantor, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AVTR
DXCM DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages DexCom, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DXCM
Macquarie Value Fund Q3 2025 Sales And Purchases
Macquarie Value Fund Q3 2025 Contributors And Detractors
This Hedge Fund's Materion Stake Tops $38 Million as Earnings Strength Pushes Shares Near Record Highs
Fed Rate Decision, Oracle, Costco, Broadcom, and More Stocks to Watch
Prologis announces redemption of 3.00% Notes due 2026
Looking for Top ETFs? Here's One to Consider Now.
Silver (XAG) Forecast: Price Prediction Points Higher if Fed Confirms 2026 Rate Cuts
Hedge Fund Buys 622,500 Knowles Shares as Stock Outperforms S&P 500 — Should You?
Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake?
Think Palantir Stock Is Expensive? This 1 Chart Might Change Your Mind.
1 Quantum Computing Stock to Buy Hand Over Fist in December
Arons: 2026 Looks "Pretty Good," Likes AMZN, LULU, META
Vertex Stock: Why One Fund Lifted Its $94.3 Million Position Even as Shares Sank
Incyte Gets FDA Breakthrough Therapy Fast Track For Rare Blood Cancer Drug
Costco's Trump Lawsuit and Q1 2026 Earnings: What Investors Need to Watch
Warren Buffett Is Sending a Clear Warning As 2026 Approaches: 3 Things Investors Should Do
Apple's executive shake-up continues.
Why One Fund Just Put $23.5 Million Into Champion Homes Despite an 18% Stock Slide
UiPath Shares Surge. Is It Too Late to Buy the Stock?
2 Things Every GE Vernova Investor Needs to Know
Forget Medtronic, Buy This Healthcare Stock Instead
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
Centuri Stock Up 18% This Year: What a New $17 Million Position Signals for Investors
10 Energy Stocks to Buy Right Now
3 Top Stocks to Buy for 2026
BTDR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Bitdeer Technologies Group Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
FDG: One Of The Few Outperformers In 2025
3 No-Brainer Growth Stocks to Buy for 2026 With $100 Right Now
EPU: A Mining ETF With A Large-Cap Bank
Evaluating VRT Stock's Actual Performance
Why One Investor Just Doubled Down on Clearwater Analytics Stock with a $45 Million Position
Oracle: Why This Selloff Looks Like An Early Christmas Gift
Apple stock under pressure after major executive departures: what it means for AAPL's AI roadmap
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Lantheus Holdings, Inc. (LNTH)
WPP DEADLINE TOMORROW: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages WPP plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action - WPP
3 Incredible Growth Stocks to Buy Now
Down 27%, Should You Buy Adobe Stock Before Dec. 10?
Financial Institutions Is Still Worth Banking On
'Trump accounts,' explained: Who qualifies, how they work and when you can claim
Netflix Stock Up 13%. Why $82.7 Billion $WBD Buy Makes $NFLX A Sell
Better Buy for 2026: ExxonMobil or Chevron?
Fulcrum Therapeutics, Inc. (FULC) Discusses New Clinical Data From the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease Transcript
Value Fund Cuts nCino Stake After $152 Million Quarter: What Long-Term Investors Should Know
Coinbase starts onboarding users again in India, plans for fiat on-ramp next year
Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET
American Electric Power: Unmatched Reach Make It A Buy
The Merger Fund Q3 2025 Contributors And Detractors
Brookfield, GIC near binding offer for National Storage, Bloomberg News reports
As Growth Accelerates, Is It Time to Buy CrowdStrike Stock?
Cellnex Telecom Is Now A 'Strong Buy'
Exxon Mobil's 43 Year Dividend Streak Looks Secure Despite Falling Earnings
3 Yield-Producing ETFs with Real Staying Power
'PROJECT TALON': Northrop Grumman reveals new 'autonomous wingman'
1 Vanguard ETF I'm Buying in 2026 and Holding Forever
NDMO: I Generally Get Cautious After Sharp Pops Higher (Rating Downgrade)
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO
Why 10%+ Yields Can Wreck Your Retirement Income
Prediction: Nvidia Stock Is Going to Soar Past $300 in 2026
Kessler Topaz Meltzer & Check, LLP Reminds StubHub Holdings, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit
How to trade Apple stock options
Best Marijuana Stocks to Watch Right Now
Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock
Core Scientific's Meltdown Over, Accelerating AI Monetization From FY 2026
Why QuantumScape Stock Got Crushed in November
Better ETF: Is VCLT's Focus on Corporate Bonds the Superior Approach to TLT's U.S. Treasuries?
Paloma Dumps 200,000 Lattice Semiconductor LSCC Shares in $9.8 Million Exit
Why I'm Buying This ETF Like There's No Tomorrow, and Never Selling
Anthony Scaramucci on Solana's Unsung Crypto Story, MSTR "Levered" Play
American Airlines requests notices in Spirit bankruptcy proceedings
Incyte's First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
Rio Tinto: Reorganization First, Re-Rating Next
Nayax Considering an Offering of Notes and Warrants in Israel
2 Stocks That Could Soar by 52% and 282%, According to Wall Street
FNDA Is A Good Alternative To Large-Cap ETFs Like VUG
Vaalco Energy: Cash Flow Update
UIVM: Unconvincing Blend Of Value And Momentum
ATYR DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs
The Cut Countdown
MLTX Deadline: MLTX Investors with Losses in Excess of $100K Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
DEFT UPCOMING DEADLINE: Faruqi & Faruqi Reminds In DeFi Technologies Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 30, 2026 - DEFT
FLY DEADLINE: Faruqi & Faruqi Reminds Firefly Aerospace Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 - FLY
The Market Is Giving Investors an Unbeatable Opportunity to Buy This Long-Term Artificial Intelligence (AI) Winner (Hint: Not Palantir or Nvidia)
VICI Properties: The Drop I Anticipated Arrived (Rating Upgrade)
STUB DEADLINE: Faruqi & Faruqi Reminds StubHub Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 23, 2026 - STUB
KMX DEADLINE: Faruqi & Faruqi Reminds Baxter International Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 2, 2026 - KMX
GitLab Shares Plunge. Why It May Be Time to Load Up on the Stock Ahead of the New Year.
FCX DEADLINE: Faruqi & Faruqi Reminds Freeport-McMoran Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 12, 2026 - FCX
Victoria's Secret: The Brand Is Regaining Momentum
BTDR DEADLINE: Faruqi & Faruqi Reminds Bitdeer Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 2, 2026 - BTDR
Capricor: Maintaining 'Hold' Rating On Randomized Phase 3 HOPE-3 Trial Win With Deramiocel
AVTR DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor
Palantir Crushes 63% Growth While UiPath Celebrates Its First Profit
위험 공개:파생상품은 장외 마진 거래로, 높은 수준의 위험을 수반하며 모든 투자자에게 적합하지 않을 수 있습니다. 이러한 제품은 모든 투자자에게 적합하지 않습니다. 거래하기 전에 위험을 충분히 이해하고 재정 상황과 거래 경험을 신중하게 고려하십시오. 필요한 경우 독립적인 재정 조언을 구하십시오.
BCR Co Pty Ltd (회사번호 1975046)은 영국령 버진아일랜드 법률에 따라 설립된 회사로, 등록 사무소는 Trident Chambers, Wickham’s Cay 1, Road Town, Tortola, British Virgin Islands에 있습니다. 본사는 영국령 버진아일랜드 금융서비스위원회로부터 라이선스 번호 SIBA/L/19/1122에 따라 인가 및 규제를 받고 있습니다.
Open Bridge Limited (회사번호 16701394)는 2006년 회사법에 따라 설립되어 영국과 웨일즈에 등록된 회사로, 등록 주소는 Kemp House, 160 City Road, London, City Road, London, England, EC1V 2NX입니다. 이 기관은 결제 처리 전용으로 운영되며, 거래 또는 투자 서비스를 제공하지 않습니다.